Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain

Nucleic Acids Research

Volumn 33, Issue 16, 2005, Pages 5235-5242

  Crouch, D H ^d   Fisher, F ^a   La Rocca, S A ^b   Goding, C R ^a   Gillespie, D A F ^c  

^a MARIE CURIE RESEARCH INSTITUTE   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HELIX LOOP HELIX PROTEIN; ISOLEUCINE; LEUCINE; LEUCINE ZIPPER PROTEIN; MAX PROTEIN; MUTANT PROTEIN; MYC PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; MYC ASSOCIATED FACTOR X; ONCOPROTEIN;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION FUNCTION; DINUCLEOTIDE REPEAT; EMBRYO; GENE DELETION; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; STATISTICAL SIGNIFICANCE; UPREGULATION; VIRUS MUTATION; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; CHEMISTRY; CHICK EMBRYO; DIMERIZATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BINDING SITES; CHICK EMBRYO; DIMERIZATION; DNA-BINDING PROTEINS; HELIX-LOOP-HELIX MOTIFS; LEUCINE ZIPPERS; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEIN P55(V-MYC); PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MYC; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 24944538418     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki832     Document Type: Article

References (31)

1. Frame,M.C. (2004) Newest findings on the oldest oncogene; how activated Src does it. J. Cell Sci., 117, 989-998.
2. McCubrey,J.A., Shelton,J.G., Steelman,L.S., Franklin,R.A., Sreevalsan,T. and McMahon,M. (2004) Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells. Oncogene, 23, 7810-7820.
3. Acquaviva,C., Salvat,C., Brockly,F., Bossis,G., Ferrara,P., Piechaczyk,M.P. and Jariel-Encontre,J. (2001) Cellular and vial Fos proteins are degraded by different proteolyic systems. Oncogene, 20, 942-950.
4. Dai,T., Rubie,E., Franklin,C.C., Kraft,A., Gillespie,D.A., Avruch,J., Kyriakis,J.M. and Woodgett,J.R. (1995) Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function. Oncogene, 10, 849-855.
5. Kanei-Ishii,C., Nomura,T., Tanikawa,J., Ichikawa-Iwata,E. and Ishii,S. (2001) Differential sensitivity of v-Myb and c-Myc to Wnt-1-induced protein degradation. J. Biol. Chem., 279, 44582-44589.
6. Cole,M.D. and McMahon,S.B. (1999) The Myc oncoprotein: A critical evaluation of transactivation and target gene regulation. Oncogene, 18, 2916-2924.
7. Gavine,P.R., Neil,J.C. and Crouch,D.H. (1999) Protein stabilization: A common consequence of mutations in independently derived v-Myc alleles. Oncogene, 18, 7552-7558.
8. Hoang,A.T., Lutterbach,B., Lewis,B.C., Yano,T., Chou,T.Y., Barrett,J.F., Raffeld,M., Hann,S.R. and Dang,C.V. (1995) A link between increased transforming activity of lymphoma-derived Myc mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol., 15, 4031-4042.
9. Petropoulos,C.J., Givol,J. and Hughes,S.H. (1996) Comparative analysis of the structure and function of the chicken c-myc and v-myc genes: v-myc is a more potent inducer of cell proliferation and apoptosis than c-myc. Oncogene, 12, 2611-2623.
10. Henriksson,M., Bakardjiev,A., Klein,G. and Luscher,B. (1993) Phosphorylation sites mapping in the N-terminal domain of c-Myc modulate its transforming potential. Oncogene, 8, 3199-3209.
11. Walther,N., Jansen,H., Trachmann,C. and Bister,K. (1986) Nucleotide sequence of the CMII v-myc allele. Virology, 154, 219-223.
12. Lutterbach,B. and Hann,S.R. (1994) Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol. Cell. Biol., 14, 5510-5522.
13. Salghetti,S., Kim,S.Y. and Tansey,W.P. (1999) Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J., 18, 717-726.
14. Flinn,E.M., Busch,C.M. and Wright,A.P. (1998) Myc boxes, which are conserved in myc family of proteins, are signals for protein degradation via the proteasome. Mol. Cell. Biol., 18, 5961-5969.
15. Muhle-Goll,C., Nilges,M. and Pastore,A. (1995) The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers. Biochemistry, 34, 13554-13564.
16. Crouch,D.H., Gallagher,R., Goding,C.R., Neil,J.C. and Fulton,R. (1996) Multiple phenotypes associated with Myc-induced transformation of chick embryo fibroblasts can be dissociated by a basic region mutation. Nucleic Acids Res., 24, 3216-3221.
17. La Rocca,S.A., Crouch,D.H. and Gillespie,D.A.F. (1994) c-Myc inhibits myogenic differentiation and MyoD expression by a mechanism which can be dissociated from cell-transformation. Oncogene, 9, 3499-3508.
18. Crouch,D.H., Lang,C. and Gillespie, D.A.F. (1990) The leucine zipper domain of avian cMyc is required for transformation and autoregulation. Oncogene, 5, 683-689.
19. Crouch,D.H., Fisher,F., Clark,W., Jayaraman,P.S., Goding,C.R. and Gillespie,D.A.F. (1993) Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA-binding and transcriptional activation in yeast correlates with transforming capacity. Oncogene, 8, 1849-1855.
20. Batchelor,C.L., Woodward,A.M. and Crouch,D.H. (2004) Nuclear ERM (ezrin, radixin, moesin) proteins: Regulation by cell density and nuclear import. Exp. Cell Res., 296, 208-222.
21. Littlewood,T.D., Amati,B., Land,H. and Evan,G.I. (1992) Max and c-Myc/ Max DNA-binding activities in cell extracts. Oncogene, 7, 1783-1792.
22. Fisher,F., Jayaraman,P.-S. and Goding,C.R. (1991) c-Myc and the yeast transcription factor PHO4 share a common CACGTG-binding motif. Oncogene, 6, 1099-1104.
23. Jayaraman,P.-S., Hirst,K. and Goding,C.R. (1994)The activation domain of a basic helix-loop-helix protein is masked by repressor interaction with domains distinct from that required for transcription regulation. EMBO J., 13, 2192-2199.
24. Fuerstenberg,S., Beug,H., Introna,M., Khazaie,K., Munoz,A., Ness.,S., Nordstrom,K., Sap,J., Stanley,I., Zenke,M. et al. (1990) Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector. J. Virol., 64, 5891-5902.
25. Lee,C.M. and Reddy,E.K. (1999) The v-myc oncogene. Oncogene, 18, 2997-3003.
26. Sollenberger,K.G., Kao,T.-L. and Taparowsky,E.J. (1994) Structural analysis of the chicken max gene. Oncogene, 9, 661-664.
27. Luscher,B. and Larsson,L.-G. (1999) The basic region/helix-loop-helix zipper domain of Myc proto-oncoproteins: Function and regulation. Oncogene, 18, 2955-2966.
28. Fisher,F., Crouch,D.H., Jayaraman,P.S., Clark,W., Gillespie,D.A.F. and Goding,C.R. (1993) Transcription activation By Myc and Max: Flanking sequences target activation to a subset of CACGTG motifs in vivo. EMBO J., 12, 5075-5082.
29. Jean-Francois,N., Frederic,G., Raymund,W., Benoit,C. and Lavigne,P. (2003) Improving the thermodynamic stability of the leucine zipper of Max increases the stability of its b-HLH-LZ:E:box complex. J. Mol. Biol., 326, 1577-1595.
30. Sakamuro,D. and Prendergast,G.C. (1999) New Myc-interacting proteins: A second Myc network emerges. Oncogene, 18, 2942-2954.
31. Nieddu,E., Melchiori,A., Pescarolo,M.P., Bagnasco,L., Biasotti,B., Licheri,B., Malacarne,D., Tortolina,L., Castagnino,N., Pasa,S. et al. (2005) Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-Myc. FASEB J., 19, 632-634.